
UC Davis researchers achieve total synthesis of ibogaine
UC Davis researchers achieve a breakthrough in synthesising ibogaine, enabling safer drug developmen...
UC Davis researchers achieve a breakthrough in synthesising ibogaine, enabling safer drug developmen...
UK Biocentre has expanded its sample storage capacity with the addition of Azenta's BioArc Ultra, ad...
Glox Therapeutics has received a portion of a £3 million fund to combat antimicrobial resistance in ...
UC Davis researchers achieve a breakthrough in synthesising ibogaine, enabling safer drug development for addiction and depression treatment....
UK Biocentre has expanded its sample storage capacity with the addition of Azenta's BioArc Ultra, adding space for 16 million more samples to support vital health research. ...
Glox Therapeutics has received a portion of a £3 million fund to combat antimicrobial resistance in cystic fibrosis patients. ...
Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying early biomarkers for Parkinson's disease (PD)....
Unlock Exclusive Industry Insights